Atlas Trials

A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

Clinical trial NCT05662215 · TERMINATED

Trial details

NCT number
NCT05662215
Sponsor
Cytokinetics
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2022-12-06
Primary completion
2023-08-08
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.